LYMPHOMA, MANTLE-CELL
Clinical trials for LYMPHOMA, MANTLE-CELL explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, MANTLE-CELL trials appear
Sign up with your email to follow new studies for LYMPHOMA, MANTLE-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise in battling advanced blood cancers
Disease control OngoingThis early-stage study tests an experimental pill called LOXO-338 in people with advanced blood cancers (like certain leukemias, lymphomas, and multiple myeloma) who have already tried standard treatments. The main goals are to find the safest dose and to see if the drug can shri…
Matched conditions: LYMPHOMA, MANTLE-CELL
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 12, 2026 13:51 UTC
-
New combo therapy aims to slow mantle cell lymphoma
Disease control OngoingThis study tests whether adding the targeted drug acalabrutinib to standard chemotherapy (bendamustine and rituximab) helps people with untreated mantle cell lymphoma live longer without their cancer getting worse. About 635 adults aged 65 and older will take part. The goal is to…
Matched conditions: LYMPHOMA, MANTLE-CELL
Phase: PHASE3 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
CAR t cell therapy: 15-Year safety check begins for lymphoma patients
Knowledge-focused OngoingThis study follows about 50 people who have already received an experimental CAR T cell therapy for certain types of lymphoma. The goal is to track any long-term side effects and survival for up to 15 years after treatment. No new study drug is given, but participants may receive…
Matched conditions: LYMPHOMA, MANTLE-CELL
Sponsor: Adicet Therapeutics • Aim: Knowledge-focused
Last updated May 15, 2026 12:07 UTC